ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Association of Heart Disease with Endogenous Testosterone
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="Jinzang" data-source="post: 140962" data-attributes="member: 12925"><p>This study is getting a lot of attention in the press today. It used "Mendelian randomization." Basically, some genetic variants cause men to have lower testosterone levels and the study compared the rates of heart disease between men with and without these genetic variations. The study used data from a previous study of the use of dutasteride to prevent prostate cancer. The advantage of Mendelian randomization is that lifestyle behaviors that affect testosterone levels may have an independent effect on heart disease, but presumably the genetic variants that lower testosterone are free of these independent effects. The study concluded:</p><p></p><p>"In men, endogenous testosterone genetically predicted by variants in the <em>JMJD1C</em> gene region was positively associated with thromboembolism (odds ratio per unit increase in log transformed testosterone (nmol/L) 2.09, 95% confidence interval 1.27 to 3.46) and heart failure (7.81, 2.56 to 23.8), but not myocardial infarction (1.17, 0.78 to 1.75). Associations were less obvious in women. In the validation study, genetically predicted testosterone (based on <em>JMJD1C</em> gene region variants) was positively associated with myocardial infarction (1.37, 1.03 to 1.82)."</p><p></p><p>"Endogenous testosterone was positively associated with thromboembolism, heart failure, and myocardial infarction in men. Rates of these conditions are higher in men than women. Endogenous testosterone can be controlled with existing treatments and could be a modifiable risk factor for thromboembolism and heart failure."</p><p></p><p><a href="https://www.bmj.com/content/364/bmj.l476" target="_blank">Full text of the study</a> is available online.</p></blockquote><p></p>
[QUOTE="Jinzang, post: 140962, member: 12925"] This study is getting a lot of attention in the press today. It used "Mendelian randomization." Basically, some genetic variants cause men to have lower testosterone levels and the study compared the rates of heart disease between men with and without these genetic variations. The study used data from a previous study of the use of dutasteride to prevent prostate cancer. The advantage of Mendelian randomization is that lifestyle behaviors that affect testosterone levels may have an independent effect on heart disease, but presumably the genetic variants that lower testosterone are free of these independent effects. The study concluded: "In men, endogenous testosterone genetically predicted by variants in the [I]JMJD1C[/I] gene region was positively associated with thromboembolism (odds ratio per unit increase in log transformed testosterone (nmol/L) 2.09, 95% confidence interval 1.27 to 3.46) and heart failure (7.81, 2.56 to 23.8), but not myocardial infarction (1.17, 0.78 to 1.75). Associations were less obvious in women. In the validation study, genetically predicted testosterone (based on [I]JMJD1C[/I] gene region variants) was positively associated with myocardial infarction (1.37, 1.03 to 1.82)." "Endogenous testosterone was positively associated with thromboembolism, heart failure, and myocardial infarction in men. Rates of these conditions are higher in men than women. Endogenous testosterone can be controlled with existing treatments and could be a modifiable risk factor for thromboembolism and heart failure." [URL='https://www.bmj.com/content/364/bmj.l476']Full text of the study[/URL] is available online. [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Testosterone and Men's Health Articles
Association of Heart Disease with Endogenous Testosterone
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top